Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease ContinuumAndréa Lessa Benedet, Natàlia Vilor‐Tejedor, Alyssa Stevensson et al.|JAMA Neurology|2021Cited by 627
Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s continuum when only subtle changes in Aβ pathology are detectedMarc Suárez‐Calvet, Natàlia Vilor‐Tejedor, Thomas K. Karikari et al.|EMBO Molecular Medicine|2020Cited by 411
Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkersJuan Domingo Gispert, Gemma Salvadó, José Luís Molinuevo et al.|Alzheimer s Research & Therapy|2019Cited by 201
Association between insomnia and cognitive performance, gray matter volume, and white matter microstructure in cognitively unimpaired adultsJosé Luís Molinuevo, Oriol Grau‐Rivera, Grégory Operto et al.|Alzheimer s Research & Therapy|2020Cited by 113
Multitracer model for staging cortical amyloid deposition using PET imagingLyduine E. Collij, María Pascual, Fiona Heeman et al.|Neurology|2020Cited by 101